#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Productive Parvovirus B19 Infection of Primary Human Erythroid Progenitor Cells at Hypoxia Is Regulated by STAT5A and MEK Signaling but not HIFα


Human parvovirus B19 (B19V) causes a variety of human diseases. Disease outcomes of bone marrow failure in patients with high turnover of red blood cells and immunocompromised conditions, and fetal hydrops in pregnant women are resulted from the targeting and destruction of specifically erythroid progenitors of the human bone marrow by B19V. Although the ex vivo expanded erythroid progenitor cells recently used for studies of B19V infection are highly permissive, they produce progeny viruses inefficiently. In the current study, we aimed to identify the mechanism that underlies productive B19V infection of erythroid progenitor cells cultured in a physiologically relevant environment. Here, we demonstrate an effective reverse genetic system of B19V, and that B19V infection of ex vivo expanded erythroid progenitor cells at 1% O2 (hypoxia) produces progeny viruses continuously and efficiently at a level of approximately 10 times higher than that seen in the context of normoxia. With regard to mechanism, we show that hypoxia promotes replication of the B19V genome within the nucleus, and that this is independent of the canonical PHD/HIFα pathway, but dependent on STAT5A and MEK/ERK signaling. We further show that simultaneous upregulation of STAT5A signaling and down-regulation of MEK/ERK signaling boosts the level of B19V infection in erythroid progenitor cells under normoxia to that in cells under hypoxia. We conclude that B19V infection of ex vivo expanded erythroid progenitor cells at hypoxia closely mimics native infection of erythroid progenitors in human bone marrow, maintains erythroid progenitors at a stage conducive to efficient production of progeny viruses, and is regulated by the STAT5A and MEK/ERK pathways.


Vyšlo v časopise: Productive Parvovirus B19 Infection of Primary Human Erythroid Progenitor Cells at Hypoxia Is Regulated by STAT5A and MEK Signaling but not HIFα. PLoS Pathog 7(6): e32767. doi:10.1371/journal.ppat.1002088
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002088

Souhrn

Human parvovirus B19 (B19V) causes a variety of human diseases. Disease outcomes of bone marrow failure in patients with high turnover of red blood cells and immunocompromised conditions, and fetal hydrops in pregnant women are resulted from the targeting and destruction of specifically erythroid progenitors of the human bone marrow by B19V. Although the ex vivo expanded erythroid progenitor cells recently used for studies of B19V infection are highly permissive, they produce progeny viruses inefficiently. In the current study, we aimed to identify the mechanism that underlies productive B19V infection of erythroid progenitor cells cultured in a physiologically relevant environment. Here, we demonstrate an effective reverse genetic system of B19V, and that B19V infection of ex vivo expanded erythroid progenitor cells at 1% O2 (hypoxia) produces progeny viruses continuously and efficiently at a level of approximately 10 times higher than that seen in the context of normoxia. With regard to mechanism, we show that hypoxia promotes replication of the B19V genome within the nucleus, and that this is independent of the canonical PHD/HIFα pathway, but dependent on STAT5A and MEK/ERK signaling. We further show that simultaneous upregulation of STAT5A signaling and down-regulation of MEK/ERK signaling boosts the level of B19V infection in erythroid progenitor cells under normoxia to that in cells under hypoxia. We conclude that B19V infection of ex vivo expanded erythroid progenitor cells at hypoxia closely mimics native infection of erythroid progenitors in human bone marrow, maintains erythroid progenitors at a stage conducive to efficient production of progeny viruses, and is regulated by the STAT5A and MEK/ERK pathways.


Zdroje

1. BrownKE 2010 The expanding range of parvoviruses which infect humans. Rev Med Virol 20 231 244

2. YoungNSBrownKE 2004 Parvovirus B19. N Engl J Med 350 586 597

3. LamontRSobelJVaisbuchEKusanovicJMazaki-ToviS 2010 Parvovirus B19 infection in human pregnancy. BJOG 10-0528

4. CotmoreSFTattersallP 2005 A rolling-haipin strategy: basic mechanisms of DNA replication in the parvoviruses. KerrJCotmoreSFBloomMELindenRMParrishCR Parvoviruses London Hoddler Arond 171 181

5. TakahashiTOzawaKTakahashiKAsanoSTakakuF 1990 Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 75 603 610

6. LiuZQiuJChengFChuYYotoY 2004 Comparison of the transcription profile of simian parvovirus with that of the human erythrovirus B19 reveals a number of unique features. J Virol 78 12929 12939

7. OzawaKAyubJHaoYSKurtzmanGShimadaT 1987 Novel transcription map for the B19 (human) pathogenic parvovirus. J Virol 61 2395 2406

8. CotmoreSFTattersallP 1984 Characterization and molecular cloning of a human parvovirus genome. Science 226 1161 1165

9. OzawaKKurtzmanGYoungN 1987 Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 70 384 391

10. LeruezMPallierCVassiasIElouetJFRomeoP 1994 Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell as demonstrated by in situ hybridization. J Gen Virol 75 1475 1478

11. MoritaETadaKChisakaHAsaoHSatoH 2001 Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins. J Virol 75 7555 7563

12. MiyagawaEYoshidaTTakahashiHYamaguchiKNaganoT 1999 Infection of the erythroid cell line, KU812Ep6 with human parvovirus B19 and its application to titration of B19 infectivity. J Virol Methods 83 45 54

13. WongSBrownKE 2006 Development of an improved method of detection of infectious parvovirus B19. J Clin Virol 35 407 413

14. ShimomuraSWongSBrownKEKomatsuNKajigayaS 1993 Early and late gene expression in UT-7 cells infected with B19 parvovirus. Virology 194 149 156

15. SolNLeJJVassiasIFreyssinierJMThomasA 1999 Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73 8762 8770

16. WongSZhiNFilipponeCKeyvanfarKKajigayaS 2008 Ex vivo-generated CD36+ erythroid progenitors are highly permissive to human parvovirus B19 replication. J Virol 82 2470 2476

17. FilipponeCFranssilaRKumarASaikkoLKovanenPE 2010 Erythroid progenitor cells expanded from peripheral blood without mobilization or preselection: molecular characteristics and functional competence. PLoS ONE 5 e9496

18. PilletSLeGNHoferTNguyenKhacFKokenM 2004 Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells. Virology 327 1 7

19. MajmundarAJWongWJSimonMC 2010 Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40 294 309

20. BrownKEAndersonSMYoungNS 1993 Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262 114 117

21. MunakataYSaito-ItoTKumura-IshiiKHuangJKoderaT 2005 Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106 3449 3456

22. Weigel-KelleyKAYoderMCSrivastavaA 2003 Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102 3927 3933

23. Weigel-KelleyKAYoderMCSrivastavaA 2001 Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells. J Virol 75 4110 4116

24. ChenAYGuanWLouSLiuZKleiboekerS 2010 Role of Erythropoietin Receptor Signaling in Parvovirus B19 Replication in Human Erythroid Progenitor Cells. J Virol 84 12385 12396

25. LodishHFGhaffariSSocolovskyMTongWZhangJ 2009 Intracellular signaling by the erythropoietin receptor. ElliottSGFooteMAMolineuxG Erythropoietins, Erythropoietic Factors and Erythropoiesis Switzerland Birkhäuser Verlag 155 174

26. ZhiNZadoriZBrownKETijssenP 2004 Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318 142 152

27. ChenAYZhangEYGuanWChengFKleiboekerS 2010 The small 11 kDa non-structural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells. Blood 115 1070 1080

28. ChenZGuanWChengFChenAYQiuJ 2009 Molecular characterization of human parvovirus B19 genotypes 2 and 3. Virology 394 276 285

29. IvanMKondoKYangHKimWValiandoJ 2001 HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292 464 468

30. JaakkolaPMoleDRTianYMWilsonMIGielbertJ 2001 Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 468 472

31. KimKSRajagopalVGonsalvesCJohnsonCKalraVK 2006 A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells. J Immunol 177 7211 7224

32. TemesEMartin-PuigSAcosta-IborraBCastellanosMCFeijoo-CuaresmaM 2005 Activation of HIF-prolyl hydroxylases by R59949, an inhibitor of the diacylglycerol kinase. J Biol Chem 280 24238 24244

33. NagataYTakahashiNDavisRJTodokoroK 1998 Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood 92 1859 1869

34. KolonicsAApatiAJanossyJBrozikAGatiR 2001 Activation of Raf/ERK1/2 MAP kinase pathway is involved in GM-CSF-induced proliferation and survival but not in erythropoietin-induced differentiation of TF-1 cells. Cell Signal 13 743 754

35. KerenyiMAOrkinSH 2010 Networking erythropoiesis. J Exp Med 207 2537 2541

36. MullerJSperlBReindlWKiesslingABergT 2008 Discovery of chromone-based inhibitors of the transcription factor STAT5. Chembiochem 9 723 727

37. MellitzerGWesselyODeckerTMeinkeAHaymanMJ 1996 Activation of Stat 5b in erythroid progenitors correlates with the ability of ErbB to induce sustained cell proliferation. Proc Natl Acad Sci U S A 93 9600 9605

38. AriyoshiKNosakaTYamadaKOnishiMOkaY 2000 Constitutive activation of STAT5 by a point mutation in the SH2 domain. J Biol Chem 275 24407 24413

39. OhoriMKinoshitaTOkuboMSatoKYamazakiA 2005 Identification of a selective ERK inhibitor and structural determination of the inhibitor-ERK2 complex. Biochem Biophys Res Commun 336 357 363

40. FavataMFHoriuchiKYManosEJDaulerioAJStradleyDA 1998 Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273 18623 18632

41. BrunetAPagesGPouyssegurJ 1994 Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenicity when expressed in fibroblasts. Oncogene 9 3379 3387

42. OzawaKKurtzmanGYoungN 1986 Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233 883 886

43. SrivastavaALuL 1988 Replication of B19 parvovirus in highly enriched hematopoietic progenitor cells from normal human bone marrow. J Virol 62 3059 3063

44. CipolleschiMGDelloSPOlivottoM 1993 The role of hypoxia in the maintenance of hematopoietic stem cells. Blood 82 2031 2037

45. ParmarKMauchPVergilioJASacksteinRDownJD 2007 Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 104 5431 5436

46. TakuboKGodaNYamadaWIriuchishimaHIkedaE 2010 Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 7 391 402

47. GuanWWongSZhiNQiuJ 2009 The genome of human parvovirus B19 virus can replicate in non-permissive cells with the help of adenovirus genes and produces infectious virus. J Virol 83 9541 9553

48. VincentKAPirainoSTWadsworthSC 1997 Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products. J Virol 71 1897 1905

49. ZhiNMillsIPLuJWongSFilipponeC 2006 Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 80 5941 5950

50. WoutersBGKoritzinskyM 2008 Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 8 851 864

51. RogersHMYuXWenJSmithRFibachE 2008 Hypoxia alters progression of the erythroid program. Exp Hematol 36 17 27

52. KanekoHShimizuRYamamotoM 2010 GATA factor switching during erythroid differentiation. Curr Opin Hematol 17 163 168

53. WinterSSHowardTWareRE 1996 Regulation of expression of the human erythropoietin receptor gene. Blood Cells Mol Dis 22 214 224

54. WalrafenPVerdierFKadriZChretienSLacombeC 2005 Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 105 600 608

55. BaoHJacobs-HelberSMLawsonAEPentaKWickremaA 1999 Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood 93 3757 3773

56. WierengaATVellengaESchuringaJJ 2010 Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/progenitor cell proliferation. Blood 115 4367 4376

57. SchuringaJJChungKYMorroneGMooreMA 2004 Constitutive activation of STAT5A promotes human hematopoietic stem cell self-renewal and erythroid differentiation. J Exp Med 200 623 635

58. RubioloCPiazzollaDMeisslKBeugHHuberJC 2006 A balance between Raf-1 and Fas expression sets the pace of erythroid differentiation. Blood 108 152 159

59. PleschkaS 2008 RNA viruses and the mitogenic Raf/MEK/ERK signal transduction cascade. Biol Chem 389 1273 1282

60. MoffatJFGreenblattRJ 2010 Effects of varicella-zoster virus on cell cycle regulatory pathways. Curr Top Microbiol Immunol 342 67 77

61. FanMMTamburicLShippam-BrettCZagrodneyDBAstellCR 2001 The small 11-kDa protein from B19 parvovirus binds growth factor receptor-binding protein 2 in vitro in a Src homology 3 domain/ligand-dependent manner. Virology 291 285 291

62. WanZZhiNWongSKeyvanfarKLiuD 2010 Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors. J Clin Invest 120 3530 3544

63. McCubreyJASteelmanLSChappellWHAbramsSLWongEW 2007 Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 1773 1263 1284

64. GuanWChengFYotoYKleiboekerSWongS 2008 Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome. J Virol 82 9951 9963

65. OnishiMNosakaTMisawaKMuiALGormanD 1998 Identification and characterization of a constitutively active STAT5 mutant that promotes cell proliferation. Mol Cell Biol 18 3871 3879

66. ChenAYLuoYChengFSunYQiuJ 2010 Bocavirus infection induces a mitochondrion-mediated apoptosis and cell cycle arrest at G2/M-phase. J Virol 84 5615 5626

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2011 Číslo 6
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#